Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityOther Non-Current LiabilitiesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Payables (2021)

Goldenwell Biotech's Payables history spans 1 years, with the latest figure at $111488.0 for Q4 2021.

  • For Q4 2021, Payables changed N/A year-over-year to $111488.0; the TTM value through Dec 2021 reached $111488.0, changed N/A, while the annual FY2021 figure was $111488.0, N/A changed from the prior year.
  • Payables reached $111488.0 in Q4 2021 per GWLL's latest filing, up from $103125.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $111488.0 in Q4 2021 to a low of $103125.0 in Q2 2021.